Cell Cycle/Checkpoint

The cell cycle is consisted of 4 main phases: Gap 1 (G1), DNA replication (S), Gap 2 (G2), and mitosis (M). There are “checkpoints” mechanism regulates the transition between these phases, at the G1/S boundary, in the S-phase and during G2/M phases. Cell can only pass through these checkpoints when signaling factors are activated and free of DNA damage. Important proteins that control cell cycle events and checkpoints are cullins, cyclins, cyclin-dependent kinases (Cdks), p53 and their inhibitors etc. Cdks family (Cdk2, Cdk3, Cdk4 and Cdk6) are Ser/Thr kinases that regulate cell cycle progression in association with cyclin binding partners (cyclin D, cyclin E and cyclin A) during all four phases. p53 halts the cell cycle if the DNA is damaged and allowing time for DNA repair to progress; it can also initiate apoptosis if DNA damage is too severe to be repaired.
-   A8335 Palbociclib (PD0332991) Isethionate1 CitationTarget: Cyclin-Dependent KinasesSummary: CDK4/6 inhibitor,highly selective A8335 Palbociclib (PD0332991) Isethionate1 CitationTarget: Cyclin-Dependent KinasesSummary: CDK4/6 inhibitor,highly selective
-   B4757 INH6Summary: Hec1/Nek2 inhibitor, potent B4757 INH6Summary: Hec1/Nek2 inhibitor, potent
-   A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Selective Aurora A/Flt3 inhibitor A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Selective Aurora A/Flt3 inhibitor
-   A8326 AZD-54382 CitationTarget: Cyclin-Dependent KinasesSummary: Potent CDK1/2/9 inhibitor A8326 AZD-54382 CitationTarget: Cyclin-Dependent KinasesSummary: Potent CDK1/2/9 inhibitor
-   B3680 GriseofulvinSummary: Microtubule associated inhibitor B3680 GriseofulvinSummary: Microtubule associated inhibitor
-   A4129 ENMD-2076 L-(+)-Tartaric acidSummary: Aurora kinases inhibitor A4129 ENMD-2076 L-(+)-Tartaric acidSummary: Aurora kinases inhibitor
-   A8316 PD 0332991 (Palbociclib) HCl15 CitationTarget: Cyclin-Dependent KinasesSummary: CDK4/6 inhibitor A8316 PD 0332991 (Palbociclib) HCl15 CitationTarget: Cyclin-Dependent KinasesSummary: CDK4/6 inhibitor
-   B3387 EribulinSummary: synthetic analogue of halichondrin B B3387 EribulinSummary: synthetic analogue of halichondrin B
-   A4128 PF-03814735Target: Aurora KinasesSummary: Aurora A/B inhibitor A4128 PF-03814735Target: Aurora KinasesSummary: Aurora A/B inhibitor
-   A5719 AT7519Target: Cyclin-Dependent KinasesSummary: Multi-CDK inhibitor A5719 AT7519Target: Cyclin-Dependent KinasesSummary: Multi-CDK inhibitor
